Accelerate Diagnostics, Inc is a diagnostics & research business based in the US. Accelerate Diagnostics shares (AXDX) are listed on the NASDAQ and all prices are listed in US Dollars. Accelerate Diagnostics employs 224 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Accelerate Diagnostics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AXDX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Accelerate Diagnostics stock price (NASDAQ: AXDX)Use our graph to track the performance of AXDX stocks over time.
Accelerate Diagnostics shares at a glance
|Latest market close||$7.59|
|52-week range||$6.44 - $16.47|
|50-day moving average||$7.91|
|200-day moving average||$8.84|
|Wall St. target price||$13.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.60|
Buy Accelerate Diagnostics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Accelerate Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Accelerate Diagnostics price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||-9.54%|
|3 months (2021-04-29)||2.43%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
Accelerate Diagnostics financials
|Revenue TTM||$11.3 million|
|Gross profit TTM||$4.5 million|
|Return on assets TTM||-38.56%|
|Return on equity TTM||0%|
|Market capitalisation||$439.5 million|
TTM: trailing 12 months
Shorting Accelerate Diagnostics shares
There are currently 7.8 million Accelerate Diagnostics shares held short by investors – that's known as Accelerate Diagnostics's "short interest". This figure is 2% down from 7.9 million last month.
There are a few different ways that this level of interest in shorting Accelerate Diagnostics shares can be evaluated.
Accelerate Diagnostics's "short interest ratio" (SIR)
Accelerate Diagnostics's "short interest ratio" (SIR) is the quantity of Accelerate Diagnostics shares currently shorted divided by the average quantity of Accelerate Diagnostics shares traded daily (recently around 213869.09942165). Accelerate Diagnostics's SIR currently stands at 36.31. In other words for every 100,000 Accelerate Diagnostics shares traded daily on the market, roughly 36310 shares are currently held short.
However Accelerate Diagnostics's short interest can also be evaluated against the total number of Accelerate Diagnostics shares, or, against the total number of tradable Accelerate Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accelerate Diagnostics's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Accelerate Diagnostics shares in existence, roughly 130 shares are currently held short) or 0.2806% of the tradable shares (for every 100,000 tradable Accelerate Diagnostics shares, roughly 281 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Accelerate Diagnostics.
Find out more about how you can short Accelerate Diagnostics stock.
Accelerate Diagnostics share dividends
We're not expecting Accelerate Diagnostics to pay a dividend over the next 12 months.
Accelerate Diagnostics share price volatility
Over the last 12 months, Accelerate Diagnostics's shares have ranged in value from as little as $6.44 up to $16.465. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accelerate Diagnostics's is 1.9581. This would suggest that Accelerate Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Accelerate Diagnostics overview
Accelerate Diagnostics, Inc. , an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc.
Stocks similar to Accelerate Diagnostics
Accelerate Diagnostics in the news
Insider Weekends: William Furman Steps Up His Purchases Of Greenbrier
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results
Frequently asked questionsWhat percentage of Accelerate Diagnostics is owned by insiders or institutions?
Currently 45.48% of Accelerate Diagnostics shares are held by insiders and 41.426% by institutions. How many people work for Accelerate Diagnostics?
Latest data suggests 224 work at Accelerate Diagnostics. When does the fiscal year end for Accelerate Diagnostics?
Accelerate Diagnostics's fiscal year ends in December. Where is Accelerate Diagnostics based?
Accelerate Diagnostics's address is: 3950 South Country Club Road, Tucson, AZ, United States, 85714 What is Accelerate Diagnostics's ISIN number?
Accelerate Diagnostics's international securities identification number is: US00430H1023 What is Accelerate Diagnostics's CUSIP number?
Accelerate Diagnostics's Committee on Uniform Securities Identification Procedures number is: 004304200
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert